Trasylol is a medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery

Trasylol (aprotinin), manufactured by Bayer, is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The purpose of Trasylol is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.


Bayer withholds critical information

In September 2006, Bayer Pharmaceuticals was faulted by the FDA for not revealing during testimony the existence of a commissioned study of Trasylol that concluded Trasylol carried greater risks. The FDA was alerted to the study by one of the researchers involved.


Trasylol recall

The drug was temporarily withdrawn worldwide in 2007 after studies suggested that its use increased the risk of complications or death; after this was confirmed by follow-up studies, Trasylol was entirely and permanently recalled in May 2008, except – at least for the time being – for very restricted research use.


Do you have a Trasylol claim?

If you or your loved one has suffered a serious injury or death as a result of Trasylol, you may be entitled to compensation for medical expenses, loss of wages, and pain and suffering.

Please contact our Trasylol lawyers today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost, no-obligation legal evaluation of your case.